Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

1.

Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells.

Oksvold MP, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, Vlassov AV, Smeland EB, Neurauter A, Pedersen KW.

Clin Ther. 2014 Jun 1;36(6):847-862.e1. doi: 10.1016/j.clinthera.2014.05.010.

PMID:
24952935
[PubMed - in process]
Free Article
2.

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

Yang Y, Schmitz R, Mitala J, Whiting A, Xiao W, Ceribelli M, Wright GW, Zhao H, Yang Y, Xu W, Rosenwald A, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Wiestner A, Kruhlak MJ, Iwai K, Bernal F, Staudt LM.

Cancer Discov. 2014 Apr;4(4):480-93. doi: 10.1158/2159-8290.CD-13-0915. Epub 2014 Feb 3.

PMID:
24491438
[PubMed - in process]
3.

The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.

Kilvaer TK, Smeland E, Valkov A, Sorbye SW, Bremnes RM, Busund LT, Donnem T.

BMC Clin Pathol. 2014 Jan 20;14(1):5. doi: 10.1186/1472-6890-14-5.

PMID:
24444363
[PubMed]
Free PMC Article
4.

High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era.

Blaker YN, Eide MB, Liestøl K, Lauritzsen GF, Kolstad A, Fosså A, Smeland EB, Holte H.

Leuk Lymphoma. 2014 Mar 19. [Epub ahead of print]

PMID:
24432894
[PubMed - as supplied by publisher]
5.

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, Tubbs RR, Cook JR, Weisenburger DD, Greiner TC, Glinsmann-Gibson BJ, Fu K, Staudt LM, Gascoyne RD, Rimsza LM.

Blood. 2014 Feb 20;123(8):1214-7. doi: 10.1182/blood-2013-11-536433. Epub 2014 Jan 7.

PMID:
24398326
[PubMed - indexed for MEDLINE]
6.

Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.

Bethge N, Lothe RA, Honne H, Andresen K, Trøen G, Eknæs M, Liestøl K, Holte H, Delabie J, Smeland EB, Lind GE.

Epigenetics. 2014 Mar;9(3):428-36. doi: 10.4161/epi.27554. Epub 2013 Dec 20.

PMID:
24362313
[PubMed - in process]
Free PMC Article
7.

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma.

Brodtkorb M, Lingjærde OC, Huse K, Trøen G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie J, Holte H, Smeland EB.

Blood. 2014 Feb 13;123(7):1051-4. doi: 10.1182/blood-2013-07-512392. Epub 2013 Dec 19.

PMID:
24357726
[PubMed - indexed for MEDLINE]
8.

Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma.

Bethge N, Honne H, Hilden V, Trøen G, Eknæs M, Liestøl K, Holte H, Delabie J, Smeland EB, Lind GE.

PLoS One. 2013 Nov 19;8(11):e79602. doi: 10.1371/journal.pone.0079602. eCollection 2013.

PMID:
24260260
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

EZH2 mutations are frequent and represent an early event in follicular lymphoma.

Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S, Wang J, Lee AM, Clear A, Montoto S, Matthews J, Iqbal S, Rajnai H, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Braziel RM, Staudt LM, Wright G, Lister TA, Elemento O, Hills R, Gribben JG, Chelala C, Matolcsy A, Kohlmann A, Haferlach T, Gascoyne RD, Fitzgibbon J.

Blood. 2013 Oct 31;122(18):3165-8. doi: 10.1182/blood-2013-04-496893. Epub 2013 Sep 19.

PMID:
24052547
[PubMed - indexed for MEDLINE]
10.

Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.

Fiskvik I, Aamot HV, Delabie J, Smeland EB, Stokke T, Heim S, Holte H.

Eur J Haematol. 2013 Oct;91(4):332-8. doi: 10.1111/ejh.12171. Epub 2013 Aug 17.

PMID:
23859481
[PubMed - indexed for MEDLINE]
11.

Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy.

Wahlin BE, Sundström C, Sander B, Christensson B, Jeppsson-Ahlberg Å, Hjalmarsson E, Holte H, Østenstad B, Brown PD, Smeland EB, Kimby E.

Leuk Lymphoma. 2014 Feb;55(2):288-95. doi: 10.3109/10428194.2013.802778. Epub 2013 Jun 14.

PMID:
23662992
[PubMed - in process]
12.

Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2013 Mar 15;13:9. doi: 10.1186/1472-6890-13-9.

PMID:
23497154
[PubMed]
Free PMC Article
13.

Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.

Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H.

Leuk Lymphoma. 2013 Oct;54(10):2205-14. doi: 10.3109/10428194.2013.774392. Epub 2013 Apr 2.

PMID:
23391141
[PubMed - indexed for MEDLINE]
14.

Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

PLoS One. 2012;7(10):e47068. doi: 10.1371/journal.pone.0047068. Epub 2012 Oct 5.

PMID:
23071715
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma.

Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH.

PLoS One. 2012;7(10):e46117. doi: 10.1371/journal.pone.0046117. Epub 2012 Oct 1.

PMID:
23049692
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling.

Oksvold MP, Pedersen NM, Forfang L, Smeland EB.

FEBS Lett. 2012 Oct 19;586(20):3575-81. doi: 10.1016/j.febslet.2012.08.022. Epub 2012 Sep 6.

PMID:
22971756
[PubMed - indexed for MEDLINE]
Free Article
17.

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM.

Nature. 2012 Oct 4;490(7418):116-20. doi: 10.1038/nature11378. Epub 2012 Aug 12.

PMID:
22885699
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

SARA is dispensable for functional TGF-β signaling.

Bakkebø M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP.

FEBS Lett. 2012 Sep 21;586(19):3367-72. doi: 10.1016/j.febslet.2012.07.027. Epub 2012 Jul 20.

PMID:
22819827
[PubMed - indexed for MEDLINE]
Free Article
19.

High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.

Sorbye SW, Kilvaer T, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

Oncoimmunology. 2012 Jan 1;1(1):75-77.

PMID:
22720216
[PubMed]
Free PMC Article
20.

Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.

Sorbye SW, Kilvaer TK, Valkov A, Donnem T, Smeland E, Al-Shibli K, Bremnes RM, Busund LT.

BMC Clin Pathol. 2012 May 3;12:7. doi: 10.1186/1472-6890-12-7.

PMID:
22554285
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk